New Hope for Patients With CNS Lymphoma

Grzegorz Nowakowski, MD of Mayo Clinic discusses treatment options for primary CNS lymphoma patients who progress on BTK inhibitors. He emphasizes that while progression can be discouraging, emavusertib is available at multiple centers, including Mayo Clinic and Memorial Sloan Kettering. He encourages physicians to refer patients resistant to BTK inhibitors or those newly receiving them to clinical trials exploring this novel approach.